Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: Role of neutrophils

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Güngör, Nejla ^a   Pennings, Jeroen L A ^b   Knaapen, Ad M ^a,d   Chiu, Roland K ^a   Peluso, Marco ^c   Godschalk, Roger W L ^a   Van Schooten, Frederik J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ISPO Cancer Prevention and Research Institute   (Italy)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL FUNCTION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; MALE; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; IMMUNOLOGY;

ANIMALS; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; PNEUMONIA; TRANSCRIPTION FACTORS;

EID: 77952420079     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-24     Document Type: Article

References (43)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867. 10.1038/nature01322, 2803035, 12490959.
2. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006, 56(2):69-83. 10.3322/canjclin.56.2.69, 16514135.
3. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986, 105(4):503-507.
4. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 2001, 8(2):71-88.
5. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987, 106(4):512-518.
6. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006, 6(1):24-37. 10.1038/nrc1782, 16397525.
7. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990, 76(4):655-663.
8. Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008, 8(4):605-615. 10.1586/14737140.8.4.605, 18402527.
9. Gungor N, Knaapen AM, Peluso M, Haenen GR, Chiu RK, Godschalk RW, Schooten FJ. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2009, (doi 10.1093/mutage/gep053)..
10. Gungor N, Godschalk RW, Pachen DM, Van Schooten FJ, Knaapen AM. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. Faseb J 2007, 21(10):2359-2367. 10.1096/fj.07-8163com, 17440118.
11. Gungor N, Haegens A, Knaapen AM, Godschalk RW, Chiu RK, Wouters EF, Schooten FJ. Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo. Mutagenesis 2009,
12. Martin TR. Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000, 23(2):128-132.
13. Haegens A, Heeringa P, van Suylen RJ, Steele C, Aratani Y, O'Donoghue RJ, Mutsaers SE, Mossman BT, Wouters EF, Vernooy JH. Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. J Immunol 2009, 182(12):7990-7996. 10.4049/jimmunol.0800377, 19494324.
14. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol 2001, 24(5):569-576.
15. Lopez AF, Strath M, Sanderson CJ. Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol 1984, 57(3):489-494. 10.1111/j.1365-2141.1984.tb02923.x, 6743568.
16. Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, Milon G, Louis JA. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol 2000, 165(5):2628-2636.
17. Klebanoff SJ, Waltersdorph AM, Rosen H. Antimicrobial activity of myeloperoxidase. Methods Enzymol 1984, 105:399-403. full_text, 6328193.
18. Knaapen AM, Albrecht C, Becker A, Hohr D, Winzer A, Haenen GR, Borm PJ, Schins RP. DNA damage in lung epithelial cells isolated from rats exposed to quartz: role of surface reactivity and neutrophilic inflammation. Carcinogenesis 2002, 23(7):1111-1120. 10.1093/carcin/23.7.1111, 12117767.
19. Godschalk RW, Maas LM, Van Zandwijk N, van 't Veer LJ, Breedijk A, Borm PJ, Verhaert J, Kleinjans JC, van Schooten FJ. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis 1998, 19(5):819-825. 10.1093/carcin/19.5.819, 9635869.
20. Munnia A, Saletta F, Allione A, Piro S, Confortini M, Matullo G, Peluso M. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis 2007, 22(6):381-385. 10.1093/mutage/gem030, 17716983.
21. Munnia A, Bonassi S, Verna A, Quaglia R, Pelucco D, Ceppi M, Neri M, Buratti M, Taioli E, Garte S, et al. Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer. Free Radic Biol Med 2006, 41(9):1499-1505. 10.1016/j.freeradbiomed.2006.08.007, 17023277.
22. Seto H, Seto T, Takesue T, Ikemura T. Reaction of malonaldehyde with nucleic acid. III. Studies of the fluorescent substances released by enzymatic digestion of nucleic acids modified with malonaldehyde. Chem Pharm Bull (Tokyo) 1986, 34(12):5079-5085.
23. Baken KA, van Loveren H, Pennings JL, de Vries A, Breit TM, van Steeg H. Gene Expression Profiling of Bis(tri-n-butyltin)oxide (TBTO)-Induced Immunotoxicity in Mice and Rats. J Immunotoxicol 2006, 3(4):227-244. 10.1080/15476910601023602, 18958704.
24. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, Zhang L, Mei N, Chen T, Herman D, Goodsaid FM, et al. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 2006, 24(9):1162-1169. 10.1038/nbt1238, 17061323.
25. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57. 10.1038/nprot.2008.211, 19131956.
26. Pennings JL, Kimman TG, Janssen R. Identification of a common gene expression response in different lung inflammatory diseases in rodents and macaques. PLoS One 2008, 3(7):e2596. 10.1371/journal.pone.0002596, 2442866, 18612392.
27. Larson MA, Weber A, Weber AT, McDonald TL. Differential expression and secretion of bovine serum amyloid A3 (SAA3) by mammary epithelial cells stimulated with prolactin or lipopolysaccharide. Vet Immunol Immunopathol 2005, 107(3-4):255-264. 10.1016/j.vetimm.2005.05.006, 15996754.
28. Burch LH, Yang IV, Whitehead GS, Chao FG, Berman KG, Schwartz DA. The transcriptional response to lipopolysaccharide reveals a role for interferon-gamma in lung neutrophil recruitment. Am J Physiol Lung Cell Mol Physiol 2006, 291(4):L677-682. 10.1152/ajplung.00523.2005, 16766576.
29. Bittleman DB, Erger RA, Casale TB. Cytokines induce selective granulocyte chemotactic responses. Inflamm Res 1996, 45(2):89-95. 10.1007/BF02265121, 8907590.
30. Nagata M, Sedgwick JB, Busse WW. Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation. J Immunol 1995, 155(10):4948-4954.
31. Ransone LJ, Verma IM. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 1990, 6:539-557. 10.1146/annurev.cb.06.110190.002543, 2125830.
32. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996, 1317(2):84-94.
33. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA, Chollet-Martin S. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 1999, 93(4):1413-1421.
34. Friedman AD. Transcriptional regulation of granulocyte and monocyte development. Oncogene 2002, 21(21):3377-3390. 10.1038/sj.onc.1205324, 12032776.
35. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006, 8(12):1369-1375. 10.1038/ncb1507, 17128264.
36. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(1):50-60. 10.1513/pats.200411-056SF, 16113469.
37. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003, 417(1):3-11. 10.1016/S0003-9861(03)00283-2, 12921773.
38. Banfi B, Clark RA, Steger K, Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 2003, 278(6):3510-3513. 10.1074/jbc.C200613200, 12473664.
39. Cheng G, Ritsick D, Lambeth JD. Nox3 regulation by NOXO1, p47phox, and p67phox. J Biol Chem 2004, 279(33):34250-34255. 10.1074/jbc.M400660200, 15181005.
40. Zienolddiny S, Ryberg D, Haugen A. Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. Carcinogenesis 2000, 21(8):1521-1526. 10.1093/carcin/21.8.1521, 10910953.
41. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007, 43(8):1109-1120. 10.1016/j.freeradbiomed.2007.07.012, 17854706.
42. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004, 5(10):975-979. 10.1038/ni1116, 15454920.
43. Kline JN, Cowden JD, Hunninghake GW, Schutte BC, Watt JL, Wohlford-Lenane CL, Powers LS, Jones MP, Schwartz DA. Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med 1999, 160(1):297-303.